| __timestamp | Merck & Co., Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 11606000000 | 612613000000 |
| Thursday, January 1, 2015 | 10313000000 | 650773000000 |
| Friday, January 1, 2016 | 9762000000 | 619061000000 |
| Sunday, January 1, 2017 | 9830000000 | 628106000000 |
| Monday, January 1, 2018 | 10102000000 | 717599000000 |
| Tuesday, January 1, 2019 | 10615000000 | 964737000000 |
| Wednesday, January 1, 2020 | 8955000000 | 875663000000 |
| Friday, January 1, 2021 | 9634000000 | 886361000000 |
| Saturday, January 1, 2022 | 10042000000 | 997309000000 |
| Sunday, January 1, 2023 | 10504000000 | 1053819000000 |
| Monday, January 1, 2024 | 1053819000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of major players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two pharmaceutical giants: Merck & Co., Inc. and Takeda Pharmaceutical Company Limited, from 2014 to 2023.
Merck's SG&A expenses have shown a relatively stable trend, with a slight increase of approximately 5% over the decade, peaking in 2014 and 2023. In contrast, Takeda's expenses have surged by nearly 72%, reflecting its aggressive expansion and strategic acquisitions. Notably, Takeda's SG&A expenses in 2023 were almost 10 times higher than Merck's, highlighting its significant operational scale.
This financial insight underscores the contrasting strategies of these companies, with Merck focusing on steady growth and Takeda on rapid expansion. Missing data for 2024 suggests ongoing developments worth monitoring.
Johnson & Johnson and Merck & Co., Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Merck & Co., Inc. vs Verona Pharma plc
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and CymaBay Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Celldex Therapeutics, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Takeda Pharmaceutical Company Limited or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Takeda Pharmaceutical Company Limited vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Merus N.V.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation